Carriage of S. pneumoniae and related respiratory pathogens after PCV-7 implementation  by Sanders, E.
e al of I
T
F
S
D
T
R
T
J
S
u
i
c
t
d
f
t
h
o
s
a
t
r
c
i
i
v
y
d
h
T
F
S
D
T
R
T
A
c
m
r
i
t
a
a
i
p
a
r
v
g30 15th ICID Abstracts / International Journ
ype: Invited Presentation
inal Abstract Number: 18.003
ession: Typhoid Fever
ate: Friday, June 15, 2012
ime: 10:15-12:15
oom: Ballroom C
reatment of enteric Fever
. Farrar
Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam
With the global spread of enteric fever, the emergence of
almonella enterica serovar Paratyphi as a major pathogen (partic-
larly inAsia), the spread of drug resistance, and the global increase
n the incidence of non-Typhi salmonella, particularly in patients
oinfectedwith human immunodeﬁciency virus, there is nowmore
han ever a need for clinical research in enteric fever. There remains
iscussion among clinicians about the best treatment for enteric
ever, and large, pragmatic, well-designed, randomized controlled
rials are required to provide clear evidence. Vaccines and public
ealth measures will have the greatest long term impact on the
verall burden of disease; however, while we wait for these mea-
ures, prompt diagnosis and early treatmentwith the best available
nd affordable drug will help patients, reduce transmission within
he community, and potentially help to contain the spread of drug
esistance. A systematic approach and consensus on the design of
linical trials will improve the quality of these studies and facil-
tate the subsequent meta-analysis of the available data. Better
ntegration of clinical medicine with epidemiology, public health,
accine development, and modern laboratory science will help to
ield tangible beneﬁts for the vast number of people who have this
isease.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.078
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yphoid vaccine landscape
. Pollard
Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom
Some 27 million cases of enteric fever and over 200,000 deaths,
aused by Salmonella entericaserovar Typhi or Paratyphi, are esti-
ated to occur every year, with the highest number of cases
ecognised in South and Southeast Asia. The true burden of disease
s difﬁcult to estimate as a result of the poor sensitivity of blood cul-
ure and low sensitivity/speciﬁcity of serological tests. Paratyphoid
ccounts for up to 20-50% of disease in some geographic regions
nd is responsible for half of enteric fever in returning travellers
n the UK and US. The current licensed vaccines for typhoid (Vi
olysaccharide and live oral Ty21a vaccine) have some limitations
nd have not been widely deployed but there are no vaccines cur-
ently available for paratyphoid. For typhoid several Vi conjugate
accines are in development as well as a live oral attenuated sin-
le dose vaccine. For paratyphoid there are O-antigen conjugatenfectious Diseases 16S (2012) e2–e157
vaccines in early development and a live oral attenuated vaccine
providing the potential for comprehensive control of enteric fever.
While there is good evidence that provision of cleanwater and ade-
quate sanitation through economic development will eventually
eliminate enteric fever, the burden of infection will not be rapidly
reduced in themedium termwithout access to effective immunisa-
tion. There has been a lack of global advocacy to drive development
and implementation of typhoid vaccines until recently but there is
now growing momentum towards global prevention supported by
the Coalition Against Typhoid.
http://dx.doi.org/10.1016/j.ijid.2012.05.079
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Carriage of S. pneumoniae and related respiratory pathogens
after PCV-7 implementation
E. Sanders
Prof. in Pediatric Immunology and ID, Utrecht, Netherlands
The human nasopharynx is considered the niche from where
respiratory infections originate. Several common residents of
the nasopharyngeal microbiota, including Streptococcus pneumo-
niae,Haemophilus inﬂuenzae,Moraxella catarrhalis andStaphylococ-
cus aureus,are major contributors to respiratory and invasive
disease in childhood, especially in the youngest with their still
immature immune system. Colonisation of the upper respiratory
tract appears tobeadynamicprocess of acquisitionandelimination
of various microbial species, interacting with the host, its maturing
immune system and each other.
In the Netherlands, we performed a longitudinal randomized
controlled trial in 1003 infants investigating the effects of a 2- and
2+1-dose schedule with 7-valent pneumococcal conjugate vaccine
(PCV7) on pneumococcal presence and the potential changes in
carriage of H. inﬂuenzae, M. catarrhalis and S. aureus in children
and parents. We found a 60% reduction of PCV7-serotype pneu-
mococci and a concomitant increase of non-vaccine serotypes (in
particular serotype 19A) at age 24 months. We also found a dou-
bled prevalence of S. aureus at age 12 months, which declined in
the second year of life and no longer persisted at 24 months of age.
No signiﬁcant shifts in H. inﬂuenzae or M. catarrhalis carriage were
found.
Next, in two cross-sectional follow-up surveillance studies in
11- and 24-month-old children and parents performed 3 and
4.5 years after introduction of 3+1-dose PCV7-schedule in the
Dutch NIP, the overall pneumococcal carriage prevalence had
remained stable with PCV7-serotype pneumococci virtually absent
but substitutedbynon-PCV7serotypes.Again, a signiﬁcantlyhigher
prevalence of S. aureus was found in 11-month-old but not in 24-
month-old children. Furthermore, a higher carriage prevalence of
H. inﬂuenzae in children and parents was observed but no changes
in M. catarrhalis prevalence.
Our studies show that vaccine-induced shifts in pneumococ-
cal colonization may inﬂuence nasopharyngeal dynamics and the
presence of other respiratory pathogens, particularly S. aureus. This
may have implications for respiratory and invasive disease and
antibiotic treatment. Therefore, monitoring is mandatory.
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ensity of carriage - Can it predict pneumonia?
. Klugman
Emory University, Atlanta, GA, USA
The discovery of a diagnostic test for the etiology of pneumo-
ia that is both sensitive and speciﬁc is an important goal in the
iagnosis and treatment of the disease as well as the surveillance
f vaccines such as pneumococcal vacine that may impact the bur-
en of pneumonia. A nasopharyngeal swab is easily obtained but
he disctinction between asymptomatic carriage and pneumonia
as not been clear to date. There is evidence that upper respira-
ory viral infections increase the density of bacterial colonization
ncluding pneumococcal colonization in the nasopharynx (NP). It is
ossible that a higher density of pneumococci in the NP increases
he likelihood ofmicroaspiration and pneumonia aswell as the risk
f bacteremia.We explored therefore in adultswhether the density
f pneumococcal carriage in the NP differed between individu-
ls with X-ray conﬁrmed pneumonia and prospectively collected
amples from age and HIV status matched asymptomatic controls.
he density of pneumococci as measured by lytA real time PCR
as 10 000 fold higher among pneumonia patients than controls.
ubsequent studies have documented an association between NP
ensity using this technique and pneumoniamortality. The density
f pneumococcal carriage in adults may be a useful diagnostic test
or pneumonia and a cutoff of greater than 8000 pneumococcal lytA
roducts /ml of original sample increased the attributable fraction
f X ray conﬁrmed pneumonia to the pneumococcus from 27% to
ver 50%. This assay is readily applicable to a platform of diagnos-
ic tests using NP swabs - its usefulness in making an etiological
iagnosis of pediatric pneumonia remains to be clariﬁed as the dif-
erential increased density of pneumococci in pneumonia versus
arriage may be several logs less than in adults, as the background
ensity of carriage is higher in children than in adults. These ini-
ial observations made in the context of an African population with
high burden of HIV need to be extended to other populations,
ut density of bacterial (and viral) pathogens in the nasopharynx
ay be a useful basis for futher exploration of novel quantitative
iagnosic tests for the etiology of pneumonia.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.081nfectious Diseases 16S (2012) e2–e157 e31
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Streptococcus pneumoniae and viruses in the nasopharynx:
Interactions and immunologic responses
M. Mina
Emory University School of Medicine, Atlanta, GA, USA
It is well recognized that Inﬂuenza A virus infection (IAV) can
enhance susceptibility to and severity of bacterial respiratory infec-
tions and invasive disease, most notably those ofStreptococcus
pneumoniaeandStaphylococcus aureus. Indeed, in the absence of
preexisting underlying disease, the primary cause of mortality
associated with IAV infection is often of bacterial etiology.
Althoughenhancedsusceptibility topneumococcal invasivedis-
ease (PID) likelybeginswith increasedacquisition, colonizationand
density of pneumococci in the nasopharynx (NP) following viral
infection, the majority of work in this ﬁeld has focused on bet-
ter understanding this viral-bacterial-host interaction in the lower
respiratory tract. However, recent work from our lab, and others,
has begun to describe the immunologic responses and microbial
dynamics in the upper respiratory tract following inﬂuenza infec-
tion.
In mouse models of pneumococcal colonized mice, subsequent
infection with IAV leads to increased pneumococcal density in the
NP that is coincident with both peak viral titres, and peak rate of
cytotoxic effects on the epithelium. However, maximum pneumo-
coccal density is attained during, or just following viral clearance.
Similarly,when IAV infectionprecedespneumococcal infection, the
host NP becomes susceptible to new acquisition of pneumococci,
particularly during viral clearance.
Aberrant immunologic responses to bacterial coinfection in the
NP have also been described. A synergistic increase in Type I
interferon during IAV and pneumococcal coinfections has recently
been shown to decreasemacrophage recruitment and pneumococ-
cal clearance from the NP. As well, increases in CD25+, FoxP3+
T-regulatory cells (Tregs) following IAV infection may impede
a proper immune response to invading pathogens. Notably, an
increase in the Treg population abrogates Th17 cell proliferation,
believed to be essential in clearance of pneumococci from the
NP. Increases in neutrophil recruitment following IAV infection,
coupled with decreased macrophage recruitment and activation
may also yield increasing hospitable environments for pneumo-
coccal survival and growth. Overall, structural degradation of the
epithelial and mucosal lining of the NP coupled with aberrant
immunologic responses to bacterial coinfection result in increased
pneumococcal acquisition and density following IAV infection.
http://dx.doi.org/10.1016/j.ijid.2012.05.082
